Načítá se...
Thyroid Hormone Status in Sitosterolemia is Modified by Ezetimibe
OBJECTIVES: To assess the association between biomarkers of thyroid status and 5α-stanols in sitosterolemia (STSL) patients treated with ezetimibe (EZE). STUDY DESIGN: Eight STSL patients (16-56 years) were studied during 14 weeks off EZE therapy (OFF EZE) and 14 weeks on EZE (10 mg/d; ON EZE). Seru...
Uloženo v:
| Vydáno v: | J Pediatr |
|---|---|
| Hlavní autoři: | , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5572543/ https://ncbi.nlm.nih.gov/pubmed/28625503 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jpeds.2017.05.049 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|